My NCBISign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
  • Your browser version may not work well with NCBI's Web applications. More information here...

Results: 1 to 20 of 105

1.

N-acetyl-L-cysteine ameliorates the inflammatory disease process in experimental autoimmune encephalomyelitis in Lewis rats.

Stanislaus R, Gilg AG, Singh AK, Singh I.

J Autoimmune Dis. 2005 May 3;2(1):4.PMID: 15869713 [PubMed - as supplied by publisher]Free PMC ArticleFree textRelated citations

2.

Lovastatin treatment decreases mononuclear cell infiltration into the CNS of Lewis rats with experimental allergic encephalomyelitis.

Stanislaus R, Singh AK, Singh I.

J Neurosci Res. 2001 Oct 15;66(2):155-62.PMID: 11592110 [PubMed - indexed for MEDLINE]Related citations

3.

Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis.

Nath N, Khan M, Paintlia MK, Singh I, Hoda MN, Giri S.

J Immunol. 2009 Jun 15;182(12):8005-14. Erratum in: J Immunol. 2009 Sep 1;183(5):3551. Singh, Inderjit [added]. PMID: 19494326 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

4.

Infection of non-encapsulated species of Trichinella ameliorates experimental autoimmune encephalomyelitis involving suppression of Th17 and Th1 response.

Wu Z, Nagano I, Asano K, Takahashi Y.

Parasitol Res. 2010 Jul 27. [Epub ahead of print]PMID: 20661746 [PubMed - as supplied by publisher]Related citations

5.

Molsidomine ameliorates experimental allergic encephalomyelitis in Lewis rats.

Kwak HJ, Pae HO, Oh GS, Choi BM, Jang SI, Jung S, Chung HT.

Immunopharmacol Immunotoxicol. 2003 Feb;25(1):41-52.PMID: 12675198 [PubMed - indexed for MEDLINE]Related citations

6.

Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis.

Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, Mizuno T, Suzumura A.

Tohoku J Exp Med. 2007 Dec;213(4):329-39.PMID: 18075237 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

7.

Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin.

Stanislaus R, Gilg AG, Singh AK, Singh I.

Neurosci Lett. 2002 Nov 29;333(3):167-70.PMID: 12429374 [PubMed - indexed for MEDLINE]Related citations

8.

Stem cell based delivery of IFN-beta reduces relapses in experimental autoimmune encephalomyelitis.

Makar TK, Trisler D, Bever CT, Goolsby JE, Sura KT, Balasubramanian S, Sultana S, Patel N, Ford D, Singh IS, Gupta A, Valenzuela RM, Dhib-Jalbut S.

J Neuroimmunol. 2008 May 30;196(1-2):67-81. Epub 2008 May 8.PMID: 18471898 [PubMed - indexed for MEDLINE]Related citations

9.

5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.

Nath N, Giri S, Prasad R, Salem ML, Singh AK, Singh I.

J Immunol. 2005 Jul 1;175(1):566-74.PMID: 15972693 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

10.

Effects of the PPAR-beta agonist GW501516 in an in vitro model of brain inflammation and antibody-induced demyelination.

Defaux A, Zurich MG, Braissant O, Honegger P, Monnet-Tschudi F.

J Neuroinflammation. 2009 May 7;6:15.PMID: 19422681 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

11.

Ribavirin ameliorates experimental autoimmune encephalomyelitis in rats and modulates cytokine production.

Lavrnja I, Stojkov D, Bjelobaba I, Pekovic S, Dacic S, Nedeljkovic N, Mostarica-Stojkovic M, Stosic-Grujicic S, Rakic L, Stojiljkovic M.

Int Immunopharmacol. 2008 Sep;8(9):1282-90. Epub 2008 Jun 5.PMID: 18602075 [PubMed - indexed for MEDLINE]Related citations

12.

Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS.

Chen M, Chen G, Nie H, Zhang X, Niu X, Zang YC, Skinner SM, Zhang JZ, Killian JM, Hong J.

Eur J Immunol. 2009 Sep;39(9):2525-36.PMID: 19670379 [PubMed - indexed for MEDLINE]Related citations

13.

Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4+ T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis.

Murugaiyan G, Mittal A, Weiner HL.

J Immunol. 2008 Dec 1;181(11):7480-8.PMID: 19017937 [PubMed - indexed for MEDLINE]Free PMC ArticleFree textRelated citations

14.

Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis.

Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J, Gran B, Zhang GX, Rostami A.

J Immunol. 2007 Sep 1;179(5):3268-75.PMID: 17709543 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

15.

Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.

Imler TJ Jr, Petro TM.

Int Immunopharmacol. 2009 Jan;9(1):134-43. Epub 2008 Nov 18.PMID: 19022403 [PubMed - indexed for MEDLINE]Related citations

16.

Sinomenine, an antirheumatic alkaloid, ameliorates clinical signs of disease in the Lewis rat model of acute experimental autoimmune encephalolmyelitis.

Zeng Y, Gu B, Ji X, Ding X, Song C, Wu F.

Biol Pharm Bull. 2007 Aug;30(8):1438-44.PMID: 17666800 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

17.

Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury.

Offner H, Subramanian S, Wang C, Afentoulis M, Vandenbark AA, Huan J, Burrows GG.

J Immunol. 2005 Sep 15;175(6):4103-11.PMID: 16148160 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

18.

Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis.

Liu L, Huang D, Matsui M, He TT, Hu T, Demartino J, Lu B, Gerard C, Ransohoff RM.

J Immunol. 2006 Apr 1;176(7):4399-409.PMID: 16547278 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

19.

Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form.

Mujtaba MG, Flowers LO, Patel CB, Patel RA, Haider MI, Johnson HM.

J Immunol. 2005 Oct 15;175(8):5077-86.PMID: 16210611 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

20.

Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?

Jee Y, Liu R, Bai XF, Campagnolo DI, Shi FD, Vollmer TL.

Int Immunol. 2006 Apr;18(4):537-44. Epub 2006 Feb 15.PMID: 16481342 [PubMed - indexed for MEDLINE]Free ArticleRelated citations

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed
Write to the Help Desk